Upregulation of TNF‐alpha and Receptors Contribute to Endothelial Dysfunction in Type II Diabetes

xue gao,xiangbin xu,William M Chilian,cuihua zhang
DOI: https://doi.org/10.1096/fasebj.20.5.lb9-b
2006-01-01
The FASEB Journal
Abstract:Diabetes mellitus is a major risk factor to impair endothelial function and induce cardiovascular diseases. TNF-alpha (TNF) is expressed during a variety of inflammatory conditions. We hypothesized that impairments in coronary endothelial function in type II diabetes is due to the overexpression of TNF and TNF receptors (TNFRs). Endothelium-dependent (acetylcholine, ACh) and –independent vasodilation (sodium nitroprusside, SNP) of isolated, pressurized (60 cmH2O) coronary arterioles (50–100 μm) from lean control and Zucker diabetic fatty (ZDF, the model of type II diabetes) rats were determined. In lean rats, SNP and ACh induced dose-dependent vasodilation, but dilation to only ACh was blocked by the NOS inhibitor NG-monomethyl-L-arginine (L-NMMA, 10 μM). In ZDF rats, dilation to ACh was blunted compared to lean rats, but SNP-induced dilation was comparable. Neutralizing antibodies to TNF (72 hr treatment; 24 mg/kg, i.p.) restored NO-mediated coronary arteriolar dilation in ZDF rats, but the antibodies to TNF did not alter endothelium-dependent vasodilation in lean rats. The mRNA expression of TNFR1 significantly increased in coronary arteries, however TNFR 2 mRNA expression has no change between lean and ZDF rats. Western blotting shows the protein expression of TNF were higher in both heart and coronary arterioles in ZDF rats than those in lean rats. These results demonstrate the endothelial dysfunction occurring in type II diabetes is the result of effects of the inflammatory cytokine TNF and mainly through the overexpression of TNF-R1.
What problem does this paper attempt to address?